Skip to main content

Table 2 Prevalence of myocardial infarction and ischemic heart diseases among the participants in the Rafsanjan cohort study (n = 9990)

From: Effect of opium consumption on cardiovascular diseases – a cross- sectional study based on data of Rafsanjan cohort study

Characteristic

Myocardial infarction

P -value

Ischemic heart diseases

P -value

Opium consumption- no. (%)

< 0.001

 

< 0.001

 yes

154 (52.03)

 

313 (35.98)

 

 no

142 (47.97)

557 (64.02)

Duration of opium consumption - no. (%)

 Non-user

142 (47.97)

< 0.001

557 (64.02)

< 0.001

 ≤ 5 year

21 (7.1)

 

61 (7.01)

 

 6–10 year

21 (7.1)

52 (5.98)

 11/15 year

26 (8.78)

41 (4.71)

 16/20 year

35 (11.82)

56 (6.44)

 > 20 year

51 (17.23)

103 (11.84)

Route of opium consumption - no. (%)

< 0.001

 

< 0.001

 Smoking

140 (47.30)

 

282 (32.42)

 

 Oral consumption

14 (4.73)

 

31 (3.56)

 

Age cat- no. (%)

< 0.001

0 (0.00)

< 0.001

 35–44

18 (6.08)

 

56 (6.44)

 

 45–54

64 (21.62)

201 (23.10)

 55–64

157 (53.04)

433 (49.77)

 ≥ 65

57 (19.26)

180 (20.69)

Gender- no. (%)

< 0.001

 

0.003

 Female

85 (28.72)

 

424 (48.74)

 

 Male

211 (71.28)

446 (51.26)

Education-no. (%)

< 0.001

 

< 0.001

 Illiterate

54 (18.24)

 

175 (20.11)

 

 Elementary

84 (28.38)

263 (30.23)

 Guidance school

54 (18.24)

180 (20.69)

 Diploma

62 (20.95)

158 (18.16)

 College

42 (14.19)

94 (10.80)

Physical activity. Mean ± SD

36.66 ± 5.28

< 0.001

37.18 ± 5.28

< 0.001

Alcohol consumption- no. (%)

0.012

 

0.645

 yes

55 (18.58)

 

114 (13.12)

 

 no

241 (81.42)

755 (86.88)

 

Cigarette smoking -no. (%)

< 0.001

 

< 0.001

 yes

152 (51.35)

 

286 (32.91)

 

 no

144 (48.65)

583 (67.09)

Hookah consumption- no. (%)

0.060

 

0.065

 yes

63 (21.28)

 

130 (14.96)

 

 no

233 (78.72)

739 (85.04)

Hypertension- no. (%)

< 0.001

 

< 0.001

 yes

119 (40.20)

 

440 (50.57)

 

 no

177 (59.80)

430 (49.43)

Cholesterol- no. (%)

< 0.001

 

< 0.001

 > 200(mg/dL)

86 (29.25)

 

269 (31.10)

 

 ≤ 200 (mg/dL)

208 (70.75)

596 (68.90)

Triglycerides- no. (%)

0.224

 

0.824

 > 200 (mg/dL)

81(27.55)

 

215 (24.86)

 

 ≤ 200(mg/dL)

213 (72.45)

650 (75.14)

LDL cholesterol - no. (%)

0.103

 

0.043

 > 130 (mg/dL)

52 (17.69)

 

163 (18.84)

 

 ≤ 130 (mg/dL)

242 (82.31)

702 (81.16)

HDL cholesterol - no. (%)

0.001

 

0.069

 < 35 (mg/dL)

5 (1.70)

 

7 (0.81)

 

 ≥ 35 (mg/dL)

289 (98.30)

858 (99.19)

S.G.O.T (AST) - no. (%)

0.046

 

0.617

 ≤ 39 (U/L)

280 (95.24)

 

838 (96.88)

 

 > 39 (U/L)

14 (4.76)

27 (3.12)

S.G.P.T (ALT) - no. (%)

0.530

 

0.034

 ≤ 39 (U/L)

273 (92.86)

 

811 (93.76)

 

 > 39 (U/L)

21 (7.14)

54 (6.24)

Alkaline phosphatase- no. (%)

0.004

 

0.007

 > 306 (IU/L)

43 (14.63)

 

107 (12.37)

 

 ≤ 306 (IU/L)

251 (85.37)

758 (87.63)

BMI- no. (%)

0.065

 

0.137

 < 25

101 (34.12)

 

229 (26.32)

 

 25–29.9

121 (40.88)

359 ( ( (41.26)

 ≥ 30

74 (25.00)

282 (32.41)

Diabetes mellitus- no. (%)

< 0.001

 

< 0.001

 yes

124 (41.89)

 

343 (39.43)

 

 no

172 (58.11)

527 (60.57)

  1. BMI body mass index